Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis

NCT02274792 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02274792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02274792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2015
Completion date
November 30, 2015
Enrollment
132 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis